Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF Melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

Urbonas, V; Schadendorf, D; Zimmer, L; Danson, S; Marshall, E; Corrie, P; Wheater, M; ... Middleton, MR; + view all Urbonas, V; Schadendorf, D; Zimmer, L; Danson, S; Marshall, E; Corrie, P; Wheater, M; Plummer, E; Mauch, C; Scudder, C; Goff, M; Love, SB; Mohammed, SB; Middleton, MR; - view fewer (2018) Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF Melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial. Annals of Oncology , Article mdy500. 10.1093/annonc/mdy500 . (In press). Green open access

https://ift.tt/2r9A4WS